Novartis Investigative Site

Saitama, Saitama 330-0854

0 studies enrolling now · 3 studies all time

What they study most

Chronic Plaque-type Psoriasis, Chronic Spontaneous Urticaria

Studies at this site

• A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients — Completed
• Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU — Completed
• A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis — Completed